[Image source=Yonhap News]

[Image source=Yonhap News]

View original image


[Asia Economy Reporter Park Jihwan] The KOSPI continued its upward trend from the previous day, closing slightly higher above the 2030 level. The stock market's direction was difficult to predict as expectations for the economic normalization effects in various countries, which had been restricted due to the novel coronavirus disease (COVID-19), were mixed with concerns over the resurgence of COVID-19 and tensions from the US-China trade dispute.


According to the Korea Exchange on the 27th, the KOSPI closed at 2031.20, up 0.07% from the previous trading day. The index opened at 2027.90, down 1.88 points (-0.09%) from the previous close, and fluctuated amid heightened caution due to US-China tensions. Ultimately, it ended the session near the flat line.


By investor type, individual investors net bought stocks worth 321.3 billion KRW. In contrast, foreign investors and institutions sold stocks worth 219.3 billion KRW and 85.9 billion KRW, respectively.


Among the top market capitalization stocks, Samsung Electronics (1.32%) and Hyundai Motor Company (0.31%) rose. Meanwhile, SK Hynix (-0.61%), Samsung Biologics (-3.26%), Naver (-4.39%), and Celltrion (-0.70%) declined.


The KOSDAQ index closed at 724.59, down 4.52 points (-0.62%) from the previous day. The index opened at 728.26, down 0.85 points (-0.12%) from the previous close, showing a weak trend.


Although individual investors net bought stocks worth 428.4 billion KRW, foreign investors and institutions net sold stocks worth 291.7 billion KRW and 124.2 billion KRW, respectively, leading to the index's decline.



Among the top market capitalization stocks, Celltrion Healthcare (-4.48%), HL Biopharma (-1.50%), and Celltrion Pharm (-4.06%) fell. Seegene (1.60%) and Alteogen (9.38%) closed higher.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing